MMDX

Providing integrated diagnostic system services comprised of quantitative RNA services comprised of quantitative RNA measurement technologies including microarrays and RT-PCR to assess the disease states in tissue biopsies; Diagnostic testing using molecular diagnostic technology; Provision of diagnostic system services comprised of quantitative RNA measurement technologies including microarrays and RT-PCR to assess tissue biopsies by measuring RNA, mRNA and micro RNA expressions; Providing moleculor diagnostic testing services; Providing molecular diagnostic testing services on tissue biopsies; Providing diagnostic testing and assessment services relating to the assessment of tissue biopsies for disease diagnosis, activity, stage, potential for therapy (theranostics), response to therapy, prognosis and treatment; Converting RNA measurements into diagnostic information to assess the biopsy for diagnosis, activity, stage, potential for therapy (theranostics), response to therapy, and prognosis of the patient; Providing data analysis services in the field of diagnostic testing, assessment, management, analysis, and reporting; Providing medical diagnostic services featuring a virtual integrated diagnostic system that uses molecular technology to assess the disease state in tissue biopsies